<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Prothrombin (PT) is a target for antibodies with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA) activity </plain></SENT>
<SENT sid="1" pm="."><plain>Anti-prothrombin antibodies (aPT) were recently identified as antibodies directed toward a <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-binding protein </plain></SENT>
<SENT sid="2" pm="."><plain>aPT are a new serologic marker of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The objective was to detect aPT in a group of 46 patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> in order to correlate their presence with clinical diagnosis, laboratory and neuroradiological findings </plain></SENT>
<SENT sid="4" pm="."><plain>We tested aPT, <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA), anticardiolipin (aCL), and anti-beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I antibodies (anti-bbeta2-GPI) in 46 young women with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> aged 34-45 years and 43 patients with nonischemic <z:e sem="disease" ids="C1456669" disease_type="Disease or Syndrome" abbrv="">neurologic diseases</z:e> and 141 <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="5" pm="."><plain>Anti-prothrombin antibodies were detected by calcium-containing aPT ELISA, aCL and anti-beta2-GPI by ELISA </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> samples were screened using the activated partial thromboplastin time (aPTT); the dilute Russell viper venous time (dRVV) coagulation test was performed </plain></SENT>
<SENT sid="7" pm="."><plain>The results were statistically analyzed </plain></SENT>
<SENT sid="8" pm="."><plain>Anti-prothrombin antibodies were found in 26 (57%) of 46 <z:hpo ids='HP_0001297'>stroke</z:hpo> patients </plain></SENT>
<SENT sid="9" pm="."><plain>Out of 43 patients with nonischemic <z:e sem="disease" ids="C1112108" disease_type="Disease or Syndrome" abbrv="">neurological disorders</z:e>, 2 (4.18%) were positive for aPT </plain></SENT>
<SENT sid="10" pm="."><plain>aPT were detected in one (0.70%) of the <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="11" pm="."><plain>Ten <z:hpo ids='HP_0001297'>stroke</z:hpo> patients (21%) were positive for IgG aPT only, 9 <z:hpo ids='HP_0001297'>stroke</z:hpo> patients (18.2%) for IgM aPT only, and 8 <z:hpo ids='HP_0001297'>stroke</z:hpo> patients (16.9%) for both IgG and IgM isotypes of aPT </plain></SENT>
<SENT sid="12" pm="."><plain>Two nonischemic <z:e sem="disease" ids="C1112108" disease_type="Disease or Syndrome" abbrv="">neurological disorders</z:e> patients (4.18%) presented IgM isotype of aPT </plain></SENT>
<SENT sid="13" pm="."><plain>Patients with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> presented aPT much more frequently than the healthy controls (OR 182.00 [95% CI 23.382-1416.6]. p &lt; 0.0001) </plain></SENT>
<SENT sid="14" pm="."><plain>Patients with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> presented aPT much frequently than the nonischemic <z:e sem="disease" ids="C1112108" disease_type="Disease or Syndrome" abbrv="">neurological disorders</z:e> patients (OR 26.650 [95% CI 5.743-123.66], p &lt; 0.0001) </plain></SENT>
<SENT sid="15" pm="."><plain>When IgG or IgM aPT were considered separately, they were more frequently found in patients with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> than in healthy control group (OR 38.889 [95% CI 4.817-313.95], p &lt; 0.0001) and (OR 34.054 [95% CI 4.178-277.5], p &lt; 0.0001), respectively </plain></SENT>
<SENT sid="16" pm="."><plain>Simultaneous positive titers for both isotypes of aPT (IgG and IgM) were more frequently found in patients with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> than in healthy control group (OR 29.474 [95% CI 3.573-243.12], p &lt; 0.0001) </plain></SENT>
<SENT sid="17" pm="."><plain>Eleven <z:hpo ids='HP_0001297'>stroke</z:hpo> patients (43%) were negative for aCL, LA and anti-beta2-GPI, but positive for aPT (OR 0.03287 [95% CI 0.001794-0.6022], p &lt; 0.001) </plain></SENT>
<SENT sid="18" pm="."><plain>aCL, LA and anti-beta2-GPI were not found both in nonischemic <z:e sem="disease" ids="C1112108" disease_type="Disease or Syndrome" abbrv="">neurological disorders</z:e> patients and in healthy controls </plain></SENT>
</text></document>